Literature DB >> 17567120

On sampling of fragment space.

Gergely M Makara1.   

Abstract

Fragment-based lead discovery has over the years matured into an attractive alternative to high-throughput screening (HTS) for lead generation. Several techniques for screening libraries of typically 10(3)-10(4) fragments have been reported. In this work, the practical success rates that can be expected from the screening of fragment-like libraries was investigated via interrogating medicinal chemistry databases for several programs with virtual libraries created from commercially available reagents or with libraries of commercially available fragments. The results suggest that hits more potent than typically discovered in today's fragment-based screens can consistently be identified from realistically accessible compound sets under screening conditions similar to commonly used HTS protocols.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567120     DOI: 10.1021/jm0700316

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  The multiple roles of computational chemistry in fragment-based drug design.

Authors:  Richard Law; Oliver Barker; John J Barker; Thomas Hesterkamp; Robert Godemann; Ole Andersen; Tara Fryatt; Steve Courtney; Dave Hallett; Mark Whittaker
Journal:  J Comput Aided Mol Des       Date:  2009-06-17       Impact factor: 3.686

2.  Leveraging structure determination with fragment screening for infectious disease drug targets: MECP synthase from Burkholderia pseudomallei.

Authors:  Darren W Begley; Robert C Hartley; Douglas R Davies; Thomas E Edwards; Jess T Leonard; Jan Abendroth; Courtney A Burris; Janhavi Bhandari; Peter J Myler; Bart L Staker; Lance J Stewart
Journal:  J Struct Funct Genomics       Date:  2011-02-26

3.  Fragment screening of infectious disease targets in a structural genomics environment.

Authors:  Darren W Begley; Douglas R Davies; Robert C Hartley; Thomas E Edwards; Bart L Staker; Wesley C Van Voorhis; Peter J Myler; Lance J Stewart
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

4.  Pairwise additivity of energy components in protein-ligand binding: the HIV II protease-Indinavir case.

Authors:  Melek N Ucisik; Danial S Dashti; John C Faver; Kenneth M Merz
Journal:  J Chem Phys       Date:  2011-08-28       Impact factor: 3.488

5.  Discovery of leukotriene A4 hydrolase inhibitors using metabolomics biased fragment crystallography.

Authors:  Douglas R Davies; Bjorn Mamat; Olafur T Magnusson; Jeff Christensen; Magnus H Haraldsson; Rama Mishra; Brian Pease; Erik Hansen; Jasbir Singh; David Zembower; Hidong Kim; Alex S Kiselyov; Alex B Burgin; Mark E Gurney; Lance J Stewart
Journal:  J Med Chem       Date:  2009-08-13       Impact factor: 7.446

6.  Lessons learnt from assembling screening libraries for drug discovery for neglected diseases.

Authors:  Ruth Brenk; Alessandro Schipani; Daniel James; Agata Krasowski; Ian Hugh Gilbert; Julie Frearson; Paul Graham Wyatt
Journal:  ChemMedChem       Date:  2008-03       Impact factor: 3.466

7.  Increasing chemical space coverage by combining empirical and computational fragment screens.

Authors:  Sarah Barelier; Oliv Eidam; Inbar Fish; Johan Hollander; Francis Figaroa; Ruta Nachane; John J Irwin; Brian K Shoichet; Gregg Siegal
Journal:  ACS Chem Biol       Date:  2014-05-20       Impact factor: 5.100

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.